Almirall Mexico receives the distinction for Companies with Transparent Practices

Acknowledgement from the Ethics and Transparency Council of the Pharmaceutical Industry in Mexico 

• The certification publicly singles out pharmaceutical companies that comply with the Code of Best Practices for Promotion (CBPP)

• The CBPP establishes a general framework for pharmaceutical companies in monitoring medical samples, educational events and promotional activities
•  Promotional policies, procedures and practices  in Almirall Mexico were evaluated positively

City of Mexico/Barcelona - 8 February 2011.- The Ethics and Transparency Council of the Pharmaceutical Industry  (CETIFARMA) in Mexico has awarded Almirall Mexico the distinction for Companies with Transparent Practices. This recognition publicly commends pharmaceutical companies located in Mexico that comply with the Code of Best Practices for Promotion (CBPP). 

Almirall Mexico’s efforts in complying with the CBPP have been rewarded through the results of an audit carried out by Gestión Social y Cooperación (GESOC), an independent organisation.

According to Israel García, Almirall’s Mexico General Manager, “for a pharmaceutical company like Almirall, which is committed to people’s health, it is an honour to receive this recognition certifying that our activities are performed ethically and transparently”.

By being awarded this certificate, Almirall Mexico was rated positively in its promotional politics and practices. It underwent a thorough document assessment as well as interviews with those involved in the process. A survey was also performed with a sample of doctors to corroborate these best practices.

Code of Best Practices for Promotion (CBPP) The Code of Best Practices for Promotion establishes an action framework for promotional activities performed in Mexico by pharmaceutical companies, in which their representatives interact with doctors or other health professionals. 

The aim of the CBPP is to establish action standards of general compliance without curbing medical and scientific information exchange or preventing the organising of academic and dissemination events that drive the pharmaceutical industry’s progress in serving society.

The code was approved in March 2005 and establishes action principles that define conduct to be followed and promotes values related to honesty, transparency, veracity, impartiality and responsibility in promotional practices by pharmaceutical laboratories.

About Almirall Almirall is an international pharmaceutical company based on innovation and committed to health. Headquartered in Barcelona, Spain, it researches, develops, manufactures and commercialises its own R&D and licensed drugs with the aim of improving people’s health and wellbeing.   

Almirall focuses its research resources on therapeutic areas related to the treatment of asthma, COPD (Chronic Obstructive Pulmonary Disease), rheumatoid arthritis, multiple sclerosis, psoriasis and other dermatological conditions.

Almirall’s products are currently present in over 70 countries while it has direct presence in Europe and Latin America through 12 affiliates.

Almirall Mexico started activities in 2001 and currently commercialises medicines in the gastrointestinal, musculoskeletal, and allergy and respiratory areas, among others.

For further information please visit the website at: www.almirall.com

More information: Ketchum Pleon Victorino Ballestero  victorino.ballestero@ketchumpleon.com Tel.: 00 34 91 788 32 00